Keyword: Moderna

Chemistry & Life Sciences

The Future of mRNA Technology

20.03.2024 -

mRNA-based vaccines against the coronavirus have become firmly established in medicine since the pandemic. Nevertheless, the technology is still at the beginning of its...

News

Moderna and Immatics Collaborate on Cancer Therapies

18.09.2023 -

US vaccine maker Moderna and German biotechnology company Immatics agreed on a broad multi-platform research and development collaboration for novel cancer therapies...

News

Moderna to Build New Plant in Massachusetts

06.06.2023 -

After building up manufacturing footholds outside the US, including in Australia, Kenya, South Korea, Canada and the UK, vaccine specialist Moderna is planning to build a...

News

Baxter Said to Eye Sale of Biopharma CMO Arm

22.03.2023 -

Plans by US healthcare company Baxter International to shed its biopharma contract business as it streamlines operations after a poor 2022 earnings performance are...

Logistics & Supply Chain

Centrally Controlled Logistics for Covid-19 Vaccines

16.03.2023 -

Examples of national logistics solutions in the UK, the Netherlands and Belgium show how high availability and low costs can be brought down to a common denominator.

News

Moderna Chooses Oxfordshire Site for UK Tech Center

07.03.2023 -

US vaccine maker Moderna has chosen the Harwell Science Campus in Oxfordshire, England, as the location for its planned UK Innovation and Technology Center which is...

News

J&J Ends Mosaico HIV Vaccine Trial on poor Results

27.01.2023 -

Johnson & Johnson’s pharmaceuticals subsidiary Janssen is walking away from plans to launch an HIV vaccine in the immediate future after the data safety monitoring board...

News

Moderna Buys Japan’s OriCiro Genomics

06.01.2023 -

In its first acquisition since forming in 2010, mRNA specialist Moderna is buying Japan’s OriCiro Genomics for $85 million, expanding its therapeutics and vaccines...